[The aim of our study was to assess the main reasons for romany women to stay away from cervical cancer screening and knowledge about cervical cancer. Methods: We carried out a quantitative, cross-sectional study with non-probability convenience sampling in 2016. Our sample consists of romany women living in the agglomeration of Nagyatád, Hungary (N=126). In the questionnaire we measured reasons for non-attendance and knowledge. During statistical analysis we calculated descriptive statistics, χc2-test and t-test (p<0,05). Results: Mean age of responders is 37,45±12,05 years. 26,2% of women have not attended any kind of gynecological screening in their life. Mean age of women when they attended for screening for the first time was 24,05±8,96 years (n=91). Main score of the knowledge test is 31,4±3,93 points. According to knowledge level there is no connection between attendants and non-attendants(p>0,05). Conclusions: The lack of knowledge determines the participating willingness, to increase has been possible by organized knowledge transmitter performances.]

[The imaging staging follows the surgical FIGO staging system in the classification of gynecological carcinomas taking into account the extent of tumor invasion and lymphnode involvement. The most important prognostic factors which influence treatment are the presence of invasive disease and lymphnode metastasis. Imaging techniques for evaluation of gynecological tumor staging are: abdominal and transvaginal ultrasound, computed tomography and magnetic resonance imaging. Transabdominal ultrasound is not a reliable staging modality for gynecological tumors. Computed tomography is useful in the advanced III and IV stages of diseases, but differentiation between stages I and II is difficult. Magnetic resonance imaging showed excellent diagnostic accuracy in determining adnex masses, in the assessment of cervical as well as endometrial and ovarian cancer extension. Magnetic resonance imaging is superior in comparison to computed tomography and ultrasound, in both early and advanced stage disease. Evaluation of lymph-node involvement using computed tomography and magnetic resonance imaging rely only size criteria, which is not reliable indicator of tumor involvement.]

[Introduction - Nearly the fifth of more than 100 HPV serotypes affect the anogenital region causing genital warts, penile and anal cancer. The incidence of male pathologies is lower than that of females (genital warts, vaginal, vulvar, cervical and anal cancer), however they are equally important in epidemiological terms. Methods - The aim of our questionnaire-based cross-sectional study was to assess the HPV-related knowledge of young men in 19 randomly selected high schools in Budapest. The anonymous questionnaires contained 54 items about socio-demographic and lifestyle factors, HPV-related knowledge and the attitude toward HPV vaccination. Results - We collected 530 completed questionnaires (86.74% response rate). 35.3% of the students knew that HPV was an STD and 3.2% was aware of transmission via skin contact. The majority (52.5%) linked cervical cancer to the viral infection, 7.7% linked HPV to the genital warts of females and 8.3% to the genital warts of males, 9.8% to penile cancer and 4.2% to anal cancer. 44.7% of the young men would have their future children vaccinated, while 24.5% remained uncertain. Conclusions - The young men’s knowledge about HPV was poor and they underestimated the risk of infection. This emphasizes the importance of targeted health education in this population. However, the students were mostly in favour of the HPV vaccination.]

[Worldwide, cervical cancer remains the second most frequent malignancy. The estimated number of new cases is 450,000 per year. Approximately 80% of affected women live in developing countries where access to cervical screening programmes is limited. In Europe, more than 12,800 women die each year from this preventable disease. Human papilloma virus (HPV) infection has been proved to be a potential cause of cervical cancer. Secondary screening decreases the morbidity and mortality of the disease, but does not prevent HPV infection. HPV-DNA can be detected in 90-100% of preinvasive and invasive cervical cancer cases. Trials assessing prophylactic anti-HPV vaccination have confirmed that the vaccination is a suitable method for the primary prevention of precancer lesions and cervical cancer.]

[OBJECTIVE - The study aims to explore knowledge on cervical cancer and cervical screening among women with 9-14 yearold daughters, and learning the attitudes towards screening, the motivation of attendance at or absence from screening. DATA AND METHODS - A quantitative, cross-sectional study was conducted using our own questionnaire in the town Nagyatád in 2012. Study participants included women who had 9-14 year-old daughters and a registered home address in Nagyatád. We received valid responses from 186 people (response rate: 75.3%). RESULTS - The interviewed women’s knowledge on cervical cancer differed significantly depending on their age, education, marital status, and economic activity. Only 45 women with higher education (p=0.043) were considered to be well informed on the subject. However, their willingness to participate in cancer screening was more favorable than their knowledge, 96.2% of the women claimed to attend an annual cancer screening. The average age of respondents was 20.92 years at first visit. CONCLUSIONS - Although the participation rate was much higher compared with that in previously published studies, it is of great importance to increase the mothers’ knowledge on cervical cancer and the factors that promote its development, so that they can pass their knowledge to their children and strengthen their protection against one of the most common sexually transmitted viral infection and the development of cervical cancer.]